Acadia Pharmaceuticals (ACAD) Deferred Taxes (2026)
Acadia Pharmaceuticals' Deferred Taxes was $9.77 million in Q2 2026.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) Deferred Taxes (2026) Analysis & Trends
On a trailing twelve-month basis, Acadia Pharmaceuticals' Deferred Taxes was $9.68 million through Jun 30, 2026; for FY2025, it came in at -$249.88 million.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | -665.00 Mn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | -1.79 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | -56.00 Mn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | -612.00 Mn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | -120.00 Mn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 202.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | -860.00 Mn |
| 10 | Acadia Pharmaceuticals | 2.95 Bn | -526.50 Mn | 279.64 Mn | 9.77 Mn |
API Access
Acadia Pharmaceuticals Deferred Taxes API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=deferred-taxes&ticker=ACAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "deferred-taxes", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=deferred-taxes&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();